News digest: Firms on drug price control, RCom bond test tomorrow, and more

Argue 20-90% rise in raw material prices could lead to production issues and shortage in domestic markets

Drug firms ask govt to ease price control

Pharmaceutical companies have approached the government to raise the ceiling prices of drugs under price control, at least temporarily. If the government yields to the drugmakers’ demands, it would be a rare move under the Drug Price Control Order (DPCO) of 2013. Read more

Samsung overhauls India strategy for a comeback

Leading consumer technology firm Samsung India is transforming its business strategy, with a clear focus on the mass segment where rivals have been quick to corner market share. Read more

RCom bond test tomorrow

Reliance Communications (RCom) will offer to settle dues worth $300 million with its overseas bondholders in a meeting on Friday. Bondholders will have to either take a steep haircut on their investments or move the National Company Law Tribunal (NCLT), experts said. Read more

India cautious & sceptical towards new investors, says Liberty chief

Sanjeev Gupta, executive chairman of UK-headquartered Liberty House that is getting ready to have a strong base in the country, feels that India treats new investors with suspicion. Read more